Larkin Community Hospital
13
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
76.9%
10 terminated/withdrawn out of 13 trials
16.7%
-69.8% vs industry average
31%
4 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Artificial Intelligence vs Endoscopist Identification in EUS Normal Anatomy
Role: collaborator
Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy
Role: lead
Hypertension and Osteopathic Treatment
Role: lead
Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients
Role: lead
Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2
Role: lead
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
Role: lead
Proteomic Analysis of Sweat in Cutaneous Conditions
Role: lead
Use of Topical Euphrasia, a Homeopathic Remedy in Ophthalmology
Role: lead
Ameliorating Work Burnout and Medical Residents
Role: lead
A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection
Role: lead
Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
Role: lead
Subzero and Scorpion Trial
Role: lead
Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients
Role: lead
All 13 trials loaded